DK0527736T3 - Isoxazol-4-carboxylsyreamider og hydroxyalkyliden-cyanoacetamider, lægemidler indeholdende disse forbindelser og anvendelsen af disse lægemidler. - Google Patents

Isoxazol-4-carboxylsyreamider og hydroxyalkyliden-cyanoacetamider, lægemidler indeholdende disse forbindelser og anvendelsen af disse lægemidler.

Info

Publication number: DK0527736T3
Authority: DK; Denmark
Prior art keywords: drugs; compounds; isoxazole; hydroxyalkylidene; cyanoacetamides
Prior art date: 1990-05-18

Application number

DK90915462.7T

Other languages

English (en)

Inventor

Robert R Bartlett

Friedrich-Johannes Kaemmerer

Original Assignee

Hoechst Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-05-18

Filing date

1990-10-24

Publication date

1997-10-20

1990-10-24 Application filed by Hoechst Ag filed Critical Hoechst Ag

1997-10-20 Application granted granted Critical

1997-10-20 Publication of DK0527736T3 publication Critical patent/DK0527736T3/da

Links

150000001875 compounds Chemical class 0.000 title abstract 4
QBPXGTUBZXXKJO-UHFFFAOYSA-N 1,2-oxazole-4-carboxamide Chemical class NC(=O)C=1C=NOC=1 QBPXGTUBZXXKJO-UHFFFAOYSA-N 0.000 title abstract 3
239000003814 drug Substances 0.000 title abstract 3
229940079593 drug Drugs 0.000 title 2
208000025747 Rheumatic disease Diseases 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/23—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same unsaturated acyclic carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C317/34—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
- C07C317/38—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atom of at least one amino group being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfones
- C07C317/40—Y being a hydrogen or a carbon atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/66—Nitrogen atoms not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Hematology (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Thiazole And Isothizaole Compounds (AREA)
Hydrogenated Pyridines (AREA)
Pyridine Compounds (AREA)
Indole Compounds (AREA)
Medicinal Preparation (AREA)
Photoreceptors In Electrophotography (AREA)
Air Conditioning Control Device (AREA)

DK90915462.7T 1990-05-18 1990-10-24 Isoxazol-4-carboxylsyreamider og hydroxyalkyliden-cyanoacetamider, lægemidler indeholdende disse forbindelser og anvendelsen af disse lægemidler. DK0527736T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE4016178		1990-05-18
DE4017020		1990-05-26
DE4017043		1990-05-26

Publications (1)

Publication Number	Publication Date
DK0527736T3 true DK0527736T3 (da)	1997-10-20

Family

ID=27201216

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK90915462.7T DK0527736T3 (da)	1990-05-18	1990-10-24	Isoxazol-4-carboxylsyreamider og hydroxyalkyliden-cyanoacetamider, lægemidler indeholdende disse forbindelser og anvendelsen af disse lægemidler.

Country Status (28)

Country	Link
US (2)	US5494911A (da)
EP (1)	EP0527736B1 (da)
JP (3)	JP2995086B2 (da)
KR (1)	KR100188801B1 (da)
CN (1)	CN1051074C (da)
AT (1)	ATE151633T1 (da)
AU (2)	AU649421B2 (da)
BR (1)	BR9008022A (da)
CA (1)	CA2083179C (da)
CY (1)	CY2123B1 (da)
CZ (4)	CZ290474B6 (da)
DE (1)	DE59010701D1 (da)
DK (1)	DK0527736T3 (da)
ES (1)	ES2102367T3 (da)
FI (1)	FI105683B (da)
GR (1)	GR3023638T3 (da)
HU (1)	HU222234B1 (da)
IE (1)	IE911694A1 (da)
IL (1)	IL98163A (da)
LV (1)	LV10575B (da)
NO (1)	NO180118C (da)
NZ (1)	NZ238165A (da)
PT (1)	PT97689B (da)
RU (2)	RU2142937C1 (da)
SK (3)	SK281317B6 (da)
TW (2)	TW205004B (da)
WO (1)	WO1991017748A1 (da)
YU (1)	YU48765B (da)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ235563A (en) *	1989-10-13	1993-04-28	Merck & Co Inc	Fibrinogen receptor antagonist and pharmaceutical composition
GB9200275D0 (en) *	1992-01-08	1992-02-26	Roussel Lab Ltd	Chemical compounds
GB9300083D0 (en)	1993-01-05	1993-03-03	Roussel Lab Ltd	Chemical compounds
DK0607777T3 (da) *	1993-01-08	1999-08-16	Hoechst Ag	Anvendelse af leflunomid til inhibering af interleukin 8
ES2124800T3 (es) *	1993-01-08	1999-02-16	Hoechst Ag	Empleo de leflunomida para la inhibicion de interleuquina 1 beta.
ES2124801T3 (es) *	1993-01-08	1999-02-16	Hoechst Ag	Empleo de leflunomida para la inhibicion del factor de necrosis de tumores alfa.
DE59407412D1 (de) *	1993-01-08	1999-01-21	Hoechst Ag	Verwendung von Leflunomid zur Hemmung von Interleukin 1 alpha
TW314467B (da) *	1993-03-31	1997-09-01	Hoechst Ag
GB9313365D0 (en) *	1993-06-29	1993-08-11	Roussel Lab Ltd	Chemical compounds
DE4323636A1 (de) *	1993-07-15	1995-01-19	Hoechst Ag	Arzneistoffzubereitungen aus umhüllten, schwerstwasserlöslichen Arzneistoffen für Inhalationsarzneiformen und Verfahren zu ihrer Herstellung
GB9322781D0 (en) *	1993-11-04	1993-12-22	Roussel Lab Ltd	Aromatic amides
US6335356B1 (en)	1994-01-07	2002-01-01	Sugen, Inc.	Method of treating a patient by parenteral administration of a lipophilic compound
US5700823A (en) *	1994-01-07	1997-12-23	Sugen, Inc.	Treatment of platelet derived growth factor related disorders such as cancers
US5610173A (en) *	1994-01-07	1997-03-11	Sugen, Inc.	Formulations for lipophilic compounds
US5721277A (en) *	1995-04-21	1998-02-24	Sugen, Inc.	Compounds and methods for inhibiting hyper-proliferative cell growth
US6331555B1 (en)	1995-06-01	2001-12-18	University Of California	Treatment of platelet derived growth factor related disorders such as cancers
GB9520092D0 (en) *	1995-10-02	1995-12-06	Hoechst Roussel Ltd	Chemical compounds
DE19539638A1 (de) *	1995-10-25	1997-04-30	Hoechst Ag	Die Verwendung von Isoxazol- und Crotonsäureamidderivaten zur Behandlung von Krebserkrankungen
DE19547648A1 (de) *	1995-12-20	1997-06-26	Hoechst Ag	Zubereitung, enthaltend High Density Lipoproteine und Crotonsäureamidderivate
EP0795334B1 (de) *	1996-03-12	2006-02-01	Sanofi-Aventis Deutschland GmbH	Neuartige Prodrugs für die Therapie von Tumoren und entzündlichen Erkrankungen
DE19610955A1 (de) *	1996-03-20	1997-09-25	Hoechst Ag	Kombinationspräparat, enthaltend 5-Methylisoxazol-4-carbonsäure-(4-trifluormethyl)- anilid und N-(4-Trifluormethylphenyl)-2-cyan-3- hydroxycrotonsäureamid
US6011051A (en) *	1996-07-31	2000-01-04	Hoechst Aktiengesellschaft	Use of isoxazole and crotonamide derivatives for the modulation of apoptosis
EA002113B1 (ru)	1996-09-04	2001-12-24	Пфайзер Инк.	Производные индазола и их использование в качестве ингибиторов фосфодиэстеразы (фдэ) типа iv и продуцирования фактора некроза опухоли (фно)
DE19702988A1 (de)	1997-01-28	1998-07-30	Hoechst Ag	Isoxazol- und Crotonsäureamidderivate und deren Verwendung als Arzneimittel und Diagnostika
EP1012150A4 (en) *	1997-05-19	2002-05-29	Sugen Inc	HETEROARYLCARBOXAMIDE COMPOUNDS THAT ARE EFFECTIVE OF DISEASES CAUSED BY PROTEIN-TYROSIN-KINASE
US6316479B1 (en)	1997-05-19	2001-11-13	Sugen, Inc.	Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
EP0903345B1 (de) *	1997-08-08	2000-10-04	Aventis Pharma Deutschland GmbH	Kristallform von 5-Methylisoxazol-4-carbonsäure-(4-trifluormethyl)-anilid
IL135714A0 (en) *	1997-11-04	2001-05-20	Pfizer Prod Inc	Therapeutically active compounds based on indazole bioisostere replacement of catechol in pde4 inhibitors
ATE269295T1 (de) *	1998-04-17	2004-07-15	Parker Hughes Inst	Btk inhibitoren und verfahren zur identifizierung und verwendung
US6303652B1 (en)	1998-08-21	2001-10-16	Hughes Institute	BTK inhibitors and methods for their identification and use
US6355678B1 (en) *	1998-06-29	2002-03-12	Parker Hughes Institute	Inhibitors of the EGF-receptor tyrosine kinase and methods for their use
DE19908527C2 (de) *	1999-02-26	2001-08-30	Aventis Pharma Gmbh	Verfahren zur Kristallisation von N-(4-Trifluormethylphenyl)-5-methyl-isoxazol-4-carboxamid
CN1411373A (zh) *	1999-12-16	2003-04-16	特瓦制药工业有限公司	制备来氟米特的新方法和新晶形的来氟米特
US7217722B2 (en) *	2000-02-01	2007-05-15	Kirin Beer Kabushiki Kaisha	Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same
ES2237553T3 (es) *	2000-02-15	2005-08-01	Teva Pharmaceutical Industries Ltd.	Procedimiento para la sintesis de leflunomida.
DE10133665A1 (de) *	2001-07-11	2003-01-30	Boehringer Ingelheim Pharma	Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung
US20030055263A1 (en) *	2001-07-11	2003-03-20	Boehringer Ingelheim Pharma Kg	Carboxylic acid derivatives, medicaments comprising these compounds, their use and processes for their production
EP1487796A4 (en) *	2002-03-28	2005-11-16	Neurogen Corp	SUBSTITUTED BIARYLAMIDES AS MODULATORS OF THE C5A RECEPTOR
US6858637B2 (en)	2002-03-28	2005-02-22	Neurogen Corporation	Substituted biaryl amides as C5a receptor modulators
WO2004035571A1 (en) *	2002-10-15	2004-04-29	Rigel Pharmaceuticals, Inc.	Substituted indoles and their use as hcv inhibitors
RU2280464C2 (ru) *	2004-03-22	2006-07-27	Александр Иванович Петенко	Способ получения сухого пробиотического препарата "бацелл"
US7842815B2 (en)	2004-06-17	2010-11-30	Infinity Pharmaceuticals, Inc.	Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
MXPA06014754A (es)	2004-06-17	2007-06-22	Infinity Pharmaceuticals Inc	Compuestos y metodos para inhibir la interaccion de las proteinas bcl con los componentes de enlace.
WO2006115509A2 (en)	2004-06-24	2006-11-02	Novartis Vaccines And Diagnostics Inc.	Small molecule immunopotentiators and assays for their detection
DE102006014165A1 (de) *	2006-03-24	2007-09-27	Schebo Biotech Ag	Neue Isooxazol-Derivate und deren Verwendungen
AU2007275301A1 (en) *	2006-07-20	2008-01-24	Amgen Inc.	Substituted azole aromatic heterocycles as inhibitors of 11-beta-HSD-1
TWI389895B (zh)	2006-08-21	2013-03-21	Infinity Discovery Inc	抑制ｂｃｌ蛋白質與結合夥伴間之交互作用的化合物及方法
CA2684105C (en) *	2007-05-03	2011-09-06	Pfizer Limited	Pyridine derivatives
US20090076275A1 (en) *	2007-09-19	2009-03-19	David Robert Bolin	Diacylglycerol acyltransferase inhibitors
US8173621B2 (en)	2008-06-11	2012-05-08	Gilead Pharmasset Llc	Nucleoside cyclicphosphates
NZ593649A (en)	2008-12-23	2013-11-29	Gilead Pharmasset Llc	Nucleoside analogs
AU2009329872B2 (en)	2008-12-23	2016-07-07	Gilead Pharmasset Llc	Synthesis of purine nucleosides
PA8855601A1 (es)	2008-12-23	2010-07-27		Forformidatos de nucleósidos
MY159575A (en)	2009-04-02	2017-01-13	Merck Serono Sa	Dihydroorotate dehydrogenase inhibitors
EP2236505A1 (de) *	2009-04-03	2010-10-06	Bayer CropScience AG	Acylierte Aminopyridine und - pyridazine als Insektizide
WO2011004282A2 (en)	2009-07-09	2011-01-13	Alembic Limited	Novel polymorphic form of teriflunomide salts
SG184324A1 (en)	2010-03-31	2012-11-29	Gilead Pharmasset Llc	Nucleoside phosphoramidates
JP5820476B2 (ja)	2010-08-24	2015-11-24	アルギアックスファルマコウティカルスゲーエムベーハーＡＬＧＩＡＸＰｈａｒｍａｃｅｕｔｉｃａｌｓＧｍｂＨ	レフルノミドおよびマロノニトリラマイドの新規の使用
PT2632451T (pt)	2010-10-29	2017-12-14	Algiax Pharmaceuticals Gmbh	Utilização de malononitrilamidas na dor neuropática
WO2012110911A1 (en)	2011-02-18	2012-08-23	Alembic Pharmaceuticals Limited	Novel polymorphic form of teriflunomide
US20140057978A1 (en)	2011-03-17	2014-02-27	Algiax Pharmaceuticals Gmbh	Novel use of benzofuranylsulfonates
EP2685983B1 (en)	2011-03-17	2016-05-18	Algiax Pharmaceuticals GmbH	Novel use of imidazotriazinones
RS57962B1 (sr)	2013-02-25	2019-01-31	Aurigene Discovery Tech Ltd	Derivati trisupstituisanog benzotriazola kao inhibitori dihidroorotat oksigenaze
WO2015029063A2 (en) *	2013-08-30	2015-03-05	Msn Laboratories Private Limited	Novel polymorph of (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4-trifluoromethyl phenyl)-amide and process for the preparation thereof
EP3071199A2 (en)	2013-11-22	2016-09-28	Genzyme Corporation	Novel methods for treating neurodegenerative diseases
LT3466955T (lt)	2014-01-13	2021-02-25	Aurigene Discovery Technologies Limited	Oksazol[4,5-b]piridino ir tiazol[4,5-b]piridino darinių, kaip irak4 inhibitorių, skirtų vėžio gydymui, gamybos būdas
AU2015275730A1 (en) *	2014-06-20	2016-12-15	Aurigene Discovery Technologies Limited	Substituted indazole compounds as IRAK4 inhibitors
CN105272882B (zh) *	2014-07-23	2019-05-31	欣凯医药化工中间体（上海）有限公司	一种环保简便制备泰瑞米特的方法
US10526279B2 (en)	2015-06-17	2020-01-07	Biocon Limited	Process for the preparation of teriflunomide
BR112019017567A2 (pt)	2017-02-24	2020-03-24	Merck Patent Gmbh	Derivados de 1,4,6-trissubstituído-2-alquil-1h-benzo[d]imidazol como inibidores da di-hidro-orotato oxigenase
EP3600270B1 (en)	2017-03-31	2023-06-14	Aurigene Oncology Limited	Compounds and compositions for treating hematological disorders
HRP20211462T1 (hr)	2017-04-24	2021-12-24	Aurigene Discovery Technologies Limited	Postupci uporabe za trisupstituirane derivate benzotriazola kao inhibitora dihidroorotatne oksigenaze
US20180369206A1 (en)	2017-04-24	2018-12-27	Aurigene Discovery Technologies Limited	Methods of Use for Trisubstituted Benzotriazole Derivatives as Dihydroorotate Oxygenase Inhibitors
HUE067356T2 (hu)	2017-10-31	2024-10-28	Curis Inc	IRAK4 inhibitor és BCL-2 inhibitor kombinációban, rák kezelésére való felhasználásra
TR202022336A2 (tr)	2020-12-30	2022-07-21	Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi	A film coated tablet comprising teriflunomide
EP4319750A4 (en)	2021-04-08	2025-02-26	Curis, Inc.	COMBINATION THERAPIES FOR THE TREATMENT OF CANCER
EP4162933A1 (en)	2021-10-08	2023-04-12	Algiax Pharmaceuticals GmbH	Compound for treating non-alcoholic fatty liver disease and related diseases
CN117126078B (zh) *	2022-05-19	2025-11-25	四川大学	一类化合物及在治疗hDHODH介导的疾病中的用途
EP4382097A1 (en)	2022-11-25	2024-06-12	Sanovel Ilac Sanayi Ve Ticaret A.S.	A tablet comprising teriflunomide

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL186239B (nl) *	1975-06-05		Hoechst Ag	Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze.
DE2524959C2 (de) *	1975-06-05	1983-02-10	Hoechst Ag, 6000 Frankfurt	5-Methyl-isoxazol-4-carbonsäureanilide, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Mittel
ES448386A1 (es) *	1975-06-05	1978-04-16	Hoechst Ag	Procedimiento para la preparacion de anilidas de acido 5-me-til-isoxazol-4-carboxilico.
DE2557003A1 (de) *	1975-12-18	1977-06-23	Hoechst Ag	Neue cyanessigsaeureanilid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
DE2555789A1 (de) *	1975-12-11	1977-07-07	Hoechst Ag	Neue cyanessigsaeureanilid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
DE2655009A1 (de) *	1976-12-04	1978-06-15	Hoechst Ag	Isoxazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
DE2854439A1 (de) *	1978-12-16	1980-07-03	Hoechst Ag	Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung
DE3405727A1 (de) *	1984-02-17	1985-08-22	Hoechst Ag, 6230 Frankfurt	Isoxazol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3534440A1 (de) *	1985-09-27	1987-04-02	Hoechst Ag	Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
GB8619432D0 (en) *	1986-08-08	1986-09-17	Lilly Industries Ltd	Pharmaceutical compounds
GB8619433D0 (en) *	1986-08-08	1986-09-17	Lilly Industries Ltd	Pharmaceutical compounds
US4816467A (en) *	1987-01-09	1989-03-28	Farmitalia Carlo Erba S.R.L	Heteroaryl 3-oxo-propanenitrile derivatives, pharmaceutical compositions and use

1990
- 1990-10-24 ES ES90915462T patent/ES2102367T3/es not_active Expired - Lifetime
- 1990-10-24 RU RU94033835A patent/RU2142937C1/ru active
- 1990-10-24 DE DE59010701T patent/DE59010701D1/de not_active Expired - Lifetime
- 1990-10-24 KR KR1019920702895A patent/KR100188801B1/ko not_active Expired - Lifetime
- 1990-10-24 AT AT90915462T patent/ATE151633T1/de not_active IP Right Cessation
- 1990-10-24 EP EP90915462A patent/EP0527736B1/de not_active Expired - Lifetime
- 1990-10-24 AU AU65468/90A patent/AU649421B2/en not_active Expired
- 1990-10-24 US US07/938,048 patent/US5494911A/en not_active Expired - Lifetime
- 1990-10-24 WO PCT/EP1990/001800 patent/WO1991017748A1/de not_active Ceased
- 1990-10-24 CA CA002083179A patent/CA2083179C/en not_active Expired - Lifetime
- 1990-10-24 DK DK90915462.7T patent/DK0527736T3/da active
- 1990-10-24 HU HU9203619A patent/HU222234B1/hu active IP Right Grant
- 1990-10-24 RU RU9092016445A patent/RU2084223C1/ru active
- 1990-10-24 JP JP2514415A patent/JP2995086B2/ja not_active Expired - Lifetime
- 1990-10-24 BR BR909008022A patent/BR9008022A/pt not_active Application Discontinuation
- 1990-10-27 TW TW079109110A patent/TW205004B/zh active
- 1990-10-27 TW TW081101406A patent/TW211558B/zh active
1991
- 1991-05-16 SK SK1376-98A patent/SK281317B6/sk not_active IP Right Cessation
- 1991-05-16 IL IL9816391A patent/IL98163A/en not_active IP Right Cessation
- 1991-05-16 CZ CS19911450A patent/CZ290474B6/cs not_active IP Right Cessation
- 1991-05-16 CN CN91103182A patent/CN1051074C/zh not_active Expired - Lifetime
- 1991-05-16 SK SK1450-91A patent/SK281316B6/sk not_active IP Right Cessation
- 1991-05-16 SK SK542-99A patent/SK281318B6/sk not_active IP Right Cessation
- 1991-05-16 NZ NZ238165A patent/NZ238165A/en not_active IP Right Cessation
- 1991-05-16 PT PT97689A patent/PT97689B/pt not_active IP Right Cessation
- 1991-05-17 IE IE169491A patent/IE911694A1/en not_active IP Right Cessation
- 1991-05-20 YU YU88491A patent/YU48765B/sr unknown
1992
- 1992-11-17 FI FI925211A patent/FI105683B/fi active
- 1992-11-17 NO NO924433A patent/NO180118C/no not_active IP Right Cessation
1993
- 1993-05-07 LV LVP-93-310A patent/LV10575B/en unknown
1994
- 1994-03-23 AU AU57992/94A patent/AU662465B2/en not_active Expired
1995
- 1995-06-07 US US08/476,278 patent/US5532259A/en not_active Expired - Lifetime
- 1995-08-24 CZ CZ19952176A patent/CZ290717B6/cs not_active IP Right Cessation
- 1995-11-23 CZ CZ19953091A patent/CZ290736B6/cs not_active IP Right Cessation
- 1995-11-23 CZ CZ19953092A patent/CZ290737B6/cs not_active IP Right Cessation
1997
- 1997-05-30 GR GR970401284T patent/GR3023638T3/el unknown
1998
- 1998-09-29 CY CY9800032A patent/CY2123B1/xx unknown
1999
- 1999-03-01 JP JP05210899A patent/JP3233610B2/ja not_active Expired - Lifetime
- 1999-03-01 JP JP05210799A patent/JP3201747B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
PT97689B (pt)	1998-09-30
NO924433L (no)	1992-11-17
JPH11343285A (ja)	1999-12-14
ATE151633T1 (de)	1997-05-15
IE911694A1 (en)	1991-11-20
RU2084223C1 (ru)	1997-07-20
GR3023638T3 (en)	1997-08-29
JP3201747B2 (ja)	2001-08-27
CZ290474B6 (cs)	2002-07-17
ES2102367T3 (es)	1997-08-01
PT97689A (pt)	1992-02-28
CA2083179A1 (en)	1991-11-19
CN1056684A (zh)	1991-12-04
NO180118B (no)	1996-11-11
FI925211A0 (fi)	1992-11-17
TW205004B (da)	1993-05-01
YU88491A (sh)	1995-03-27
DE59010701D1 (de)	1997-05-22
AU649421B2 (en)	1994-05-26
NO180118C (no)	1997-02-19
EP0527736A1 (de)	1993-02-24
US5532259A (en)	1996-07-02
CZ290736B6 (cs)	2002-10-16
HU222234B1 (hu)	2003-05-28
FI925211L (fi)	1992-11-17
IL98163A (en)	1996-01-31
AU662465B2 (en)	1995-08-31
CZ290737B6 (cs)	2002-10-16
EP0527736B1 (de)	1997-04-16
WO1991017748A1 (de)	1991-11-28
SK281318B6 (sk)	2001-02-12
RU94033835A (ru)	1996-04-20
NZ238165A (en)	1994-08-26
CA2083179C (en)	2001-10-23
CS145091A3 (en)	1992-01-15
CY2123B1 (en)	2002-06-21
YU48765B (sh)	1999-11-22
JP3233610B2 (ja)	2001-11-26
JPH11322700A (ja)	1999-11-24
LV10575B (en)	1996-04-20
US5494911A (en)	1996-02-27
AU6546890A (en)	1991-12-10
LV10575A (lv)	1995-04-20
CZ290717B6 (cs)	2002-10-16
JP2995086B2 (ja)	1999-12-27
AU5799294A (en)	1994-07-07
BR9008022A (pt)	1993-04-06
NO924433D0 (no)	1992-11-17
RU2142937C1 (ru)	1999-12-20
FI105683B (fi)	2000-09-29
HUT64314A (en)	1993-12-28
HU9203619D0 (en)	1993-03-29
TW211558B (da)	1993-08-21
CN1051074C (zh)	2000-04-05
JPH05506425A (ja)	1993-09-22
IL98163A0 (en)	1992-06-21
KR100188801B1 (ko)	1999-06-01
SK281316B6 (sk)	2001-02-12
SK281317B6 (sk)	2001-02-12

Publication	Publication Date	Title
DK0527736T3 (da)	1997-10-20	Isoxazol-4-carboxylsyreamider og hydroxyalkyliden-cyanoacetamider, lægemidler indeholdende disse forbindelser og anvendelsen af disse lægemidler.
NO952869L (no)	1995-09-19	Aminosyrederivater, medikamenter inneholdende disse forbindelser og fremgangsmåter for fremstilling derav
FI96204C (fi)	1996-05-27	Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi
DK0624595T3 (da)	1999-05-17	Nor-galdesyrederivater, fremgangsmåde til deres fremstilling og anvendelse af disse forbindelser som lægemidler
IS1564B (is)	1994-12-13	Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
DK327689A (da)	1990-01-06	Diphosphonsyrederivater, fremgangsmaade til deres fremstilling og laegemidler indeholdende disse forbindelser
NO305802B1 (no)	1999-07-26	Nye forbindelser, farmas°ytiske blandinger inneholdende disse og anvendelse av disse forbindelser
DK15589A (da)	1989-07-22	Kemiske forbindelser
IS3284A7 (is)	1988-05-22	Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
DK160981C (da)	1991-10-28	Arylsulfonylurinstof-derivater, fremgangsmaade til fremstilling deraf, anvendelse af disse som terapeutisk og antineoplastisk middel samt farmaceutiske midler indeholdende saadanne derivater
FI883867A0 (fi)	1988-08-19	Anvaendning av 2-pyrimidinyl-1 -piperazinderivat.
DK0634396T3 (da)	1999-07-05	Aminosyrederivater og deres anvendelse som enkeltfalinaseinhibitorer
DK612788A (da)	1989-05-05	Alkoxyderivater af ginkolider, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende saadanne forbindelser
DK162682A (da)	1982-10-10	Oxindolderivater,deres fremstilling og anvendelse
DK0538690T3 (da)	1995-03-06	Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
DK100392D0 (da)	1992-08-10	3- og 5-substituerede 1,2,3,4-oxatriazol-5-iminforbindelser og fremgangsmaade til fremstilling deraf, farmaceutisk praeparat indeholdende disse forbindelser samt forbindelsernes anvendelse til fremstilling af laegemidler
DK0498011T3 (da)	1995-07-03	Nye salte af 2-(2,6-dichloranilino)-phenyleddikesyre, fremgangsmåde til fremstilling af disse salte og saltenes anvendelse som topisk anvendelse farmaceutiske præparater
NO883987D0 (no)	1988-09-07	Fremgangsmaate for fremstilling av n-(substituert aklyliden) kondensert bicykloalkyliden og anvendelse derav som medikamenter.
DK222886D0 (da)	1986-05-14	Propionylanilider, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende disse forbindelser
NO903016L (no)	1992-01-06	Taxolderivater, farmasoeytiske blandinger derav og fremgangsmaater til fremstilling av disse.
DK176788D0 (da)	1988-03-30	Thienyloxyeddikesyrederivater, fremgangsmaade til fremstilling af saadanne derivater og laegemiddel indeholdende disse